Market Size of Intravenous (IV) Equipment Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 4.30 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Intravenous (IV) Equipment Market Analysis
The intravenous (IV) equipment market is expected to register a CAGR of 4.3% during the forecast period.
- The sudden outbreak of COVID-19 had a severe impact on the intravenous (IV) equipment industry due to a sudden halt in surgical procedures that were non-immediate and were being postponed to decrease the burden on healthcare infrastructure. The use of intravenous therapies was restricted for the treatment of COVID-19 to reduce the chances of infection. For instance, as per the guidelines published by the National Institute of Health in July 2023, it was found that the COVID-19 Treatment Guidelines Panel recommended the utilization of IV Immunoglobulin for treating acute COVID-19 infection. Therefore, with the restricted use of IV for COVID-19 treatment, there was a considerable impact on the market studied. However, currently, the market has reached its pre-pandemic nature in terms of demand for IV equipment and is expected to witness strong growth in the coming years.
- Some of the major chronic diseases include cancer, kidney failure, and heart disease, among others, and several lifestyle disorders such as hypertension, diabetes, obesity, and depression, among others, which need critical care during their hospitalization.
- The rise in such chronic diseases is augmenting the growth of the market studied. For instance, according to the World Health Organization data published in April 2021, chronic diseases are expected to kill 41 million people each year, equivalent to 71% of all deaths globally. Also, 77% of mortality in low- and middle-income nations is attributable to chronic diseases. With the increase in the number of cancer cases and other chronic conditions, there will be a growing demand for various surgical procedures, which is believed to propel the market growth.
- Moreover, according to the Alzheimer Society of Canada, in January 2021, over 500,000 Canadians were living with dementia. By 2030, this number is expected to rise to 912,000. Similarly, according to the Fondation de France in 2021, Parkinson's disease affected around 150,000 people in France as of 2021. It also stated that the disease affects the geriatric population more. Hence, the high number of people living with chronic diseases is expected to propel the market growth in the coming years.
- However, stringent regulation and medication errors associated with infusion pumps leading to a product recall are expected to restrain the market growth over the forecast period.
Intravenous (IV) Equipment Industry Segmentation
IV administration means that the patient receives substances directly into their veins through a tube called a cannula. This could be either medication or nutrition. IV Therapy is a common practice for administering fluids to dehydrated patients, medications, chemotherapy treatments, and blood transfusions.
The intravenous (IV) equipment market is segmented by type (IV catheters, infusion pumps, securement devices, administration sets, drip chambers, and other types), end-user (hospitals, ambulatory surgical centers, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
By Type | |
IV Catheters | |
Infusion Pumps | |
Securement Devices | |
Administration Sets | |
Drip Chambers | |
Other Tyoes |
By End-User | |
Hospitals | |
Ambulatory Surgical Centers | |
Other End-Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Intravenous (IV) Equipment Market Size Summary
The intravenous (IV) equipment market is poised for growth, driven by the increasing prevalence of chronic diseases and the rising demand for surgical procedures. The market, which experienced a temporary setback due to the COVID-19 pandemic, has rebounded to pre-pandemic levels and is expected to continue expanding. The demand for IV equipment is bolstered by the need for critical care in patients with conditions such as cancer, kidney failure, and heart disease, as well as lifestyle disorders like hypertension and diabetes. The market is also influenced by the high incidence of needle-stick injuries, which has led to a preference for safer IV catheter systems. Innovations and product launches, such as B. Braun Medical Inc.'s Introcan Safety 2 IV Catheter, are further propelling the market forward.
In North America, the market growth is particularly strong due to the high number of surgical procedures and the prevalence of cardiovascular disorders and obesity. The region benefits from regulatory approvals and new product introductions, such as Baxter's Novum IQ Syringe infusion pump, which features enhanced safety and connectivity. The competitive landscape is characterized by the presence of both local and international companies, with key players like Becton, Dickinson and Company, B. Braun, and ICU Medical, Inc. holding significant market shares. These companies are driving market growth through rapid technological advancements and strategic product launches, ensuring a dynamic and evolving industry environment.
Intravenous (IV) Equipment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Chronic Diseases Coupled with Rising Geriatric Population
-
1.2.2 Increasing Number of Surgeries Globally
-
-
1.3 Market Restraints
-
1.3.1 Medication Errors Associated with Infusion Pumps Leading to Product Recalls
-
1.3.2 Stringent Regulatory Scenario
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Type
-
2.1.1 IV Catheters
-
2.1.2 Infusion Pumps
-
2.1.3 Securement Devices
-
2.1.4 Administration Sets
-
2.1.5 Drip Chambers
-
2.1.6 Other Tyoes
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Ambulatory Surgical Centers
-
2.2.3 Other End-Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Intravenous (IV) Equipment Market Size FAQs
What is the current Global Intravenous (IV) Equipment Market size?
The Global Intravenous (IV) Equipment Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029)
Who are the key players in Global Intravenous (IV) Equipment Market?
Becton, Dickinson and Company, 3M, Henry Schein, Inc., B. Braun Melsungen AG and ICU Medical, Inc. are the major companies operating in the Global Intravenous (IV) Equipment Market.